Dávid Pukancsik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dávid Pukancsik has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- István Kenessey
Department of Pathology, Forensic and Insurance Medicine Semmelweis University Budapest Hungary
6 shared publications - Zoltán Mátrai
Department of Breast and Sarcoma Surgery, National Institute of Oncology, Budapest, Hungary
5 shared publications - Mihály Újhelyi
TritonLife Medical Center, H-1135 Budapest, Hungary
4 shared publications Eszter Kovács
Department of Radiological Diagnostics, National Institute of Oncology, Budapest, Hungary
3 shared publicationsMihály Újhelyi
Department of Breast and Sarcoma Surgery, National Institute of Oncology, Budapest, Hungary
3 shared publicationsPéter Kelemen
Department of Breast and Sarcoma Surgery, National Institute of Oncology, Budapest, Hungary
3 shared publications
Latest Publications
- Open Access
- 21 October 2021
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 29 (2) , 1073-1075
ASO Visual Abstract: Retrospective Multicenter Analysis Comparing Conventional with Oncoplastic Breast-Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study
- 21 October 2021
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 29 (2) , 1073-1075
Open AccessASO Visual Abstract: Retrospective Multicenter Analysis Comparing Conventional with Oncoplastic Breast-Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study
- Open Access
- 13 October 2021
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 29 (2) , 1061-1070
Retrospective, Multicenter Analysis Comparing Conventional with Oncoplastic Breast Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study
Introduction: Recent data suggest that margins ≥2 mm after breast-conserving surgery may improve local control in invasive breast cancer (BC). By allowing large resection volumes, oncoplastic breast-conserving surgery (OBCII; Clough level II/Tübingen 5-6) may achieve better local control than conventional breast conserving surgery (BCS; Tübingen 1-2) or oncoplastic breast conservation with low resection volumes (OBCI; Clough level I/Tübingen 3-4). Methods: Data from consecutive high-risk BC patients treated in 15 centers from the Oncoplastic Breast Consortium (OPBC) network, between January 2010 and December 2013, were retrospectively reviewed. Results: A total of 3,177 women were included, 30% of whom were treated with OBC (OBCI n = 663; OBCII n = 297). The BCS/OBCI group had significantly smaller tumors and smaller resection margins compared with OBCII (pT1: 50% vs. 37%, p = 0.002; proportion with margin p < 0.001). There were significantly more re-excisions due to R1 (“ink on tumor”) in the BCS/OBCI compared with the OBCII group (11% vs. 7%, p = 0.049). Univariate and multivariable regression analysis adjusted for tumor biology, tumor size, radiotherapy, and systemic treatment demonstrated no differences in local, regional, or distant recurrence-free or overall survival between the two groups. Conclusions: Large resection volumes in oncoplastic surgery increases the distance from cancer cells to the margin of the specimen and reduces reexcision rates significantly. With OBCII larger tumors are resected with similar local, regional and distant recurrence-free as well as overall survival rates as BCS/OBCI.
- 13 October 2021
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 29 (2) , 1061-1070
Open AccessRetrospective, Multicenter Analysis Comparing Conventional with Oncoplastic Breast Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study
Introduction: Recent data suggest that margins ≥2 mm after breast-conserving surgery may improve local control in invasive breast cancer (BC). By allowing large resection volumes, oncoplastic breast-conserving surgery (OBCII; Clough level II/Tübingen 5-6) may achieve better local control than conventional breast conserving surgery (BCS; Tübingen 1-2) or oncoplastic breast conservation with low resection volumes (OBCI; Clough level I/Tübingen 3-4). Methods: Data from consecutive high-risk BC patients treated in 15 centers from the Oncoplastic Breast Consortium (OPBC) network, between January 2010 and December 2013, were retrospectively reviewed. Results: A total of 3,177 women were included, 30% of whom were treated with OBC (OBCI n = 663; OBCII n = 297). The BCS/OBCI group had significantly smaller tumors and smaller resection margins compared with OBCII (pT1: 50% vs. 37%, p = 0.002; proportion with margin p < 0.001). There were significantly more re-excisions due to R1 (“ink on tumor”) in the BCS/OBCI compared with the OBCII group (11% vs. 7%, p = 0.049). Univariate and multivariable regression analysis adjusted for tumor biology, tumor size, radiotherapy, and systemic treatment demonstrated no differences in local, regional, or distant recurrence-free or overall survival between the two groups. Conclusions: Large resection volumes in oncoplastic surgery increases the distance from cancer cells to the margin of the specimen and reduces reexcision rates significantly. With OBCII larger tumors are resected with similar local, regional and distant recurrence-free as well as overall survival rates as BCS/OBCI.
- 4 June 2019
- Published by Hindawi Limited in The Breast Journal
- Vol. 25 (5) , 922-926
Evaluation of the central pedicled, modified Wise‐pattern technique as a standard level II oncoplastic breast‐conserving surgery: A retrospective clinicopathological study of 190 breast cancer patients
Involving 207 breast cancer patients a retrospective study was performed to facilitate the acceptance of the central pedicled, modified Wise‐pattern therapeutic mammoplasty technique as a standard volume‐displacement level II oncoplastic breast‐conserving surgery (OBCS). The overall local recurrence rate was 5.8% with an average follow‐up of 43.9 months. The median time to the initiation of the adjuvant treatment was 4.9 weeks. Due to positive surgical margins, 13 (6.84%) completional surgeries were performed. In total, 45 complications (12.9%) were recorded. The median values of the esthetic outcomes represented improved cosmetic results. The modified Wise‐pattern technique could be a standard, safe and repeatable level II volume‐displacement OBCS.
- 4 June 2019
- Published by Hindawi Limited in The Breast Journal
- Vol. 25 (5) , 922-926
Evaluation of the central pedicled, modified Wise‐pattern technique as a standard level II oncoplastic breast‐conserving surgery: A retrospective clinicopathological study of 190 breast cancer patients
Involving 207 breast cancer patients a retrospective study was performed to facilitate the acceptance of the central pedicled, modified Wise‐pattern therapeutic mammoplasty technique as a standard volume‐displacement level II oncoplastic breast‐conserving surgery (OBCS). The overall local recurrence rate was 5.8% with an average follow‐up of 43.9 months. The median time to the initiation of the adjuvant treatment was 4.9 weeks. Due to positive surgical margins, 13 (6.84%) completional surgeries were performed. In total, 45 complications (12.9%) were recorded. The median values of the esthetic outcomes represented improved cosmetic results. The modified Wise‐pattern technique could be a standard, safe and repeatable level II volume‐displacement OBCS.
- 1 February 2017
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 43 (2) , 303-310
Objective decision making between conventional and oncoplastic breast-conserving surgery or mastectomy: An aesthetic and functional prospective cohort study
- 1 February 2017
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 43 (2) , 303-310
Objective decision making between conventional and oncoplastic breast-conserving surgery or mastectomy: An aesthetic and functional prospective cohort study
- 1 December 2016
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 42 (12) , 1814-1820
Does breast screening offer a survival benefit? A retrospective comparative study of oncological outcomes of screen-detected and symptomatic early stage breast cancer cases
- 1 December 2016
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 42 (12) , 1814-1820
Does breast screening offer a survival benefit? A retrospective comparative study of oncological outcomes of screen-detected and symptomatic early stage breast cancer cases